MORGAN STANLEY

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 895421 NEW YORK, NY

Back to ACAD Full portfolio

Position in ACAD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$24,333,538

-$6,168,584 QoQ

Shares Held

1,093,151

-4.3% QoQ

Ownership

0.638%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 84.58035532145148.ToString("F0")% Shared 0.ToString("F0")% None 15.419644678548527.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. ACAD ranks #83 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

All Filings in ACAD

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$24,333,538	1,093,151	-4.3%	Shares	Defined	2026-05-15
2025-12-31	$30,502,122	1,141,974	-3.9%	Shares	Defined	2026-05-27
2025-09-30	$25,360,579	1,188,406	-71.1%	Shares	Defined	2026-05-27
2025-06-30	$88,679,594	4,111,247	-12.2%	Shares	Defined	2025-08-15
2025-03-31	$77,737,836	4,680,183	-35.9%	Shares	Defined	2025-05-15
2024-12-31	$133,900,845	7,297,049	+335.4%	Shares	Defined	2025-05-15
2024-09-30	$25,774,630	1,675,854	-29.9%	Shares	Defined	2025-05-14
2024-06-30	$38,855,452	2,391,105	+63.4%	Shares	Defined	2025-05-14
2024-03-31	$27,051,086	1,463,012	+7.4%	Shares	Defined	2024-10-17
2023-12-31	$42,641,083	1,361,900	-26.6%	Shares	Defined	2024-08-16
2023-09-30	$38,686,952	1,856,380	-50.2%	Shares	Defined	2023-11-15
2023-06-30	$89,285,116	3,727,980	-4.8%	Shares	Defined	2023-08-14
2023-03-31	$73,674,724	3,914,704	+42.6%	Shares	Defined	2023-05-15
2022-12-31	$43,696,224	2,744,738	-10.6%	Shares	Defined	2023-02-14
2022-09-30	$50,243,404	3,071,113	-1.6%	Shares	Defined	2022-11-14
2022-06-30	$43,961,808	3,120,072	+231.8%	Shares	Defined	2022-10-27
2022-03-31	$22,776,049	940,382	+41.9%	Shares	Defined	2022-10-27
2021-12-31	$15,466,458	662,659	-19.3%	Shares	Defined	2022-02-14
2021-09-30	$13,640,843	821,243	-1.7%	Shares	Defined	2021-11-15
2021-06-30	$20,381,549	835,652	+30.0%	Shares	Defined	2021-08-23
2021-03-31	$16,590,686	643,050	+26.2%	Shares	Defined	2021-05-17
2020-12-31	$27,236,959	509,483	+4.9%	Shares	Defined	2021-02-16
2020-09-30	$20,032,608	485,639	+179.2%	Shares	Defined	2020-11-13
2020-06-30	$8,430,483	173,932	-4.1%	Shares	Defined	2020-08-14
2020-03-31	$7,666,008	181,444	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.